M R Luizon
Overview
Explore the profile of M R Luizon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliveira J, Ferreira R, Santos L, Marin L, Correa R, Luizon M, et al.
Genet Mol Res
. 2016 Nov;
15(4).
PMID: 27813577
Some studies of polymorphisms in prostate cancer (PCa) analyze individuals in a uniform manner, regardless of genetic ancestry. However, PCa aggressiveness differs between subjects of African descent and those of...
2.
Luizon M, Palei A, Belo V, Amaral L, Lacchini R, Duarte G, et al.
Pharmacogenomics J
. 2016 May;
17(5):427-434.
PMID: 27168100
Nicotinamide phosphorybosil transferase (NAMPT) polymorphisms affect visfatin/NAMPT levels and may affect the responsiveness to therapy in hypertensive disorders of pregnancy. We examined whether NAMPT polymorphisms (rs1319501 T>C and rs3801266 A>G),...
3.
Sandrim V, Luizon M, Palei A, Tanus-Santos J, Cavalli R
BJOG
. 2016 Feb;
123(13):2120-2128.
PMID: 26853698
Objective: To validate and to compare the circulating microRNA (miR) expression profiles between pre-eclampsia and healthy pregnant women, to perform correlation analysis of the differently expressed miRs with clinical and...
4.
Fontana V, Luizon M, Sandrim V
J Hum Hypertens
. 2014 Oct;
29(5):283-91.
PMID: 25355012
Hypertension is a leading cause of cardiovascular mortality, but only one third of patients achieve blood pressure goals despite antihypertensive therapy. Genetic polymorphisms may partially account for the interindividual variability...
5.
de Miranda J, Lacchini R, Belo V, Lanna C, Sertorio J, Luizon M, et al.
J Hum Hypertens
. 2014 Jun;
29(2):109-14.
PMID: 24943287
Obesity and the nitric oxide synthase 3 (NOS3) gene polymorphisms are associated with nitrite levels and hypertension. However, no study has tested the hypothesis that NOS3 tagSNPs rs3918226, rs3918188, rs743506...
6.
Luizon M, Palei A, Sandrim V, Amaral L, Machado J, Lacchini R, et al.
Pharmacogenomics J
. 2014 Jun;
14(6):535-41.
PMID: 24913092
Tissue inhibitor of metalloproteinase (TIMP)-1 is a major endogenous inhibitor of matrix metalloproteinase (MMP)-9, which may affect the responsiveness to therapy in hypertensive disorders of pregnancy. We examined whether TIMP-1...
7.
Belo V, Luizon M, Lacchini R, Miranda J, Lanna C, Souza-Costa D, et al.
Int J Obes (Lond)
. 2013 Oct;
39(1):130-5.
PMID: 24100423
Objective: Polymorphisms in the NAMPT gene, which encodes the adipocytokine visfatin/nicotinamide phosphorybosil transferase (NAMPT), affect the circulating visfatin/NAMPT levels and are associated with obesity and cardiovascular diseases. However, no study...
8.
9.
Luizon M, Amaral L, Palei A
J Hum Hypertens
. 2012 Sep;
27(4):278-9.
PMID: 22971750
No abstract available.
10.
Silva P, Fontana V, Luizon M, Lacchini R, Silva Jr W, Biagi C, et al.
Eur J Clin Pharmacol
. 2012 Jun;
69(2):167-77.
PMID: 22706620
Purpose: The antihypertensive effect of angiotensin-converting enzyme inhibitors (ACEi) is attributed partially to increased nitric oxide bioavailability. It is possible that functional polymorphisms in endothelial nitric oxide synthase (eNOS) and...